Top news of the week: 08.12.2021.
Companies And Industries
Biopharma is Tackling Misfolding Proteins in Parkinson’s Disease
Parkinson’s disease has been immensely challenging for biotech companies. A high rate of late-stage attrition in trials has led to a lack of approved therapies for the disease.
Beijing biotech firm banks on GM corn in race to be China's Monsanto
As China prepares to open its $120 billion corn market to genetically modified (GM) seed, little-known Dabeinong Biotechnology hopes to reap the benefits of early biotech investments and a ...
Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch, $53M series A raise
Apple Tree Partners has picked its first U.K.-based venture to launch: Adendra Therapeutics, an immunotherapy company focused on dendritic cell biology to treat cancers and autoimmune ...
China releases five-year green development plan for industrial sectors
China's industry ministry on Friday unveiled a five-year plan aimed at the green development of its industrial sectors, vowing to lower carbon emissions and pollutants and to promote ...
Little European biotech Sotio nabs a super $316M funding round for its superagonist work
In one of the biggest funding rounds for a European biotech ever, Czech Republic cancer company Sotio Biotech has grabbed a huge 280 million euro ($316 million) raise.
BioWorld
Website access to BioWorld content Full editions delivered every business day by 8 pm ET plus midday alerts and breaking news bulletins 14 days free then $393/month The news …
Chutes & Ladders—GlaxoSmithKline snags Pfizer vax leader Dormitzer
GlaxoSmithKline poached Pfizer's RNA and viral vaccines leader Phil Dormitzer, M.D., Ph.D., to shore up its vaccine business as it's lost many research staffers this past year. Parthenon ...
COVID-19 tracker: GSK-Vir win mAb antiviral UK nod, AstraZeneca drops booster testing in US
A second monoclonal antiviral was authorized for use in the U.K. by the Medicines and Healthcare products Regulatory Agency. AstraZeneca is scrapping plans for testing its vaccine as a ...